4.0
Jun 11, 2022
Former employee, more than 3 years
Recommend
CEO approval
Business Outlook
Pros
It was way back when the company had established its preclinical research set up. Great scientists were recruited and everything was great
Cons
Unfortunately the focus of the company changed and issues with top management led to spin-off to Daichi